Study on Inherited Blood Disorders
This observational study is looking into the genetic and functional causes of inherited disorders affecting blood cells and clotting. It focuses on conditions like Glanzmann thrombasthenia, which affects how platelets (small cells that help stop bleeding) work. Researchers are studying both healthy volunteers and patients with inherited disorders of red blood cells, white blood cells, platelets, or blood clotting factors. The main goal is to understand how well platelets aggregate (clump together) in these conditions. There are no specific interventions or drugs being tested. The study is currently unclear on its recruitment status.
- Study design
- This is an observational study planning to enroll 60 participants. It includes both healthy volunteers and patients with specific blood disorders.
- What's involved
- You would have a detailed history taken, a physical exam, and blood drawn for tests. You might be asked to return for additional tests.
- Compensation
- Not stated in the trial record.
- Follow-up
- Not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders.
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Barry Coller, MD · PRINCIPAL_INVESTIGATOR · Rockefeller University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Platelet aggregationminutes
The initial slope of the increase in light transmission after an agonist is added to a cuvette containing platelet-rich plasma.